TimesSquare Capital Management LLC 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-02 06:05 am Sale | 2023-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | TimesSquare Capital Management LLC | 0 0.000% | -1,429,310 (Position Closed) | Filing |
| 2023-02-03 08:16 am Purchase | 2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | TimesSquare Capital Management LLC | 1,429,310 5.360% | 1,429,310 (New Position) | Filing |